Aspen Pharmacare(FRA) LDZA

Market Cap€3.58BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€8.10
-1.82%
-0.15Today

Aspen Pharmacare Financials at a Glance

Market Cap

€3.58BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

€0.30

P/E Ratio

27.67

Dividend

€0.12

Beta (Volatility)

0.12 (Low)

Price

€8.10

Volume

0

Open

€8.10

Previous Close

€8.25

Daily Range

€8.10 - €8.10

52-Week Range

€4.54 - €8.80

Estimated Earnings Date

N/A

LDZA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Aspen Pharmacare

Aspen Pharmacare Holdings Ltd. manufactures and supplies branded and generic pharmaceutical products. It operates through the Commercial Pharmaceuticals and Manufacturing segments. The Commercial Pharmaceuticals segment consists of the following business sub segments:^Sterile Focused Brands, which includes the Anaesthetics and Thrombosis portfolios; and Regional Brands, which are products that are managed on a regional basis. The Manufacturing segment relates to the manufacture and sale of active pharmaceutical ingredient and finished dose form products to third-party customers. The company was founded by Michael Guy Attridge and Stephen Bradley Saad in 1850 and is headquartered in Durban, South Africa.

Industry

Pharmaceuticals

Sector

Health Care

Employees

7,625

CEO

Stephen Bradley Saad, PhD

Website

www.aspenpharma.com

LDZA Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-116.98%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

3.61%

Dividend Yield

1.49%

Payout Ratio

N/A

Stock Overview

Market Cap

€3.58BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

428.25M

Volume

0

Avg. Volume

67.697

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Aspen Pharmacare Performance Analysis

Aspen Pharmacare annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30EUR 2,191,370,588-2.7%
20242024-06-30EUR 2,209,121,5580.8%
20252025-06-30EUR 1,789,589,090-19.0%
20262026-06-30EUR 1,768,385,506-1.2%
Aspen Pharmacare annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30EUR 0.63-24.2%
20242024-06-30EUR 0.49-22.7%
20252025-06-30EUR -0.12N/A
20262026-06-30EUR 0.03N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

€3.58BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,803.85-0.00%
^DJIDJI
$51,687.96-0.00%
^IXICNASDAQ
$27,201.84-0.00%
BTCBitcoin
$83,069.00+0.01%

Trending Stocks

Symbol / CompanyPricePrice Chg
BACBank of America
$51.02-5.46%
CRWVCoreWeave
$65.16-16.26%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$42.53+13.65%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$110.39-13.47%

Questions About LDZA

What is the current price of Aspen Pharmacare?

Aspen Pharmacare is trading at €8.10 per share.

What is the 52-week range for Aspen Pharmacare?

Over the past 52 weeks, Aspen Pharmacare has traded between €4.54 and €8.80.

How much debt does Aspen Pharmacare have?

As of the most recent reporting period, Aspen Pharmacare reported total debt of €830.85M.

How much cash does Aspen Pharmacare have on hand?

Aspen Pharmacare reported €853.74M in cash and cash equivalents in its most recent financial results.

What is Aspen Pharmacare’s dividend yield?

Aspen Pharmacare currently has a dividend yield of 1.49%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services